Crossmark

Sickle cell disease and increased adverse maternal and perinatal outcomes in different genotypes

Crossref DOI link: https://doi.org/10.1016/j.htct.2024.02.013

Published Print: 2024-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Figueira, Camilla Olivares https://orcid.org/0000-0002-1412-8094
Guida, José Paulo S. https://orcid.org/0000-0002-3648-6159
Surita, Fernanda G. https://orcid.org/0000-0003-4335-0337
Antolini-Tavares, Arthur https://orcid.org/0000-0001-5964-4407
Saad, Sara T.

Costa, Fernando F.

Fertrin, Kleber Y.

Costa, Maria Laura https://orcid.org/0000-0001-8280-3234
Funding

Funding for this research was provided by:

CNPq
License Information

Text and Data Mining valid from 2024-11-01

Text and Data Mining valid from 2024-11-01

Version of Record valid from 2024-03-06
More Information

This article is maintained by: Elsevier

Article Title: Sickle cell disease and increased adverse maternal and perinatal outcomes in different genotypes

Journal Title: Hematology, Transfusion and Cell Therapy

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2024.02.013

Content Type: article

Copyright: © 2024 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier España, S.L.U.